vs
CNB FINANCIAL CORP（CCNE）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
CNB FINANCIAL CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$86.4M vs $75.5M），CNB FINANCIAL CORP同比增速更快（45.5% vs 27.7%），CNB FINANCIAL CORP自由现金流更多（$58.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 26.3%）
CNB金融集团（宾夕法尼亚州）是美国区域性银行控股企业，总部位于宾州，提供零售及商业银行服务，涵盖储蓄账户、个人及商业贷款、财富管理等产品，服务区域覆盖宾州、俄亥俄州及西弗吉尼亚州，客户包括个人消费者和中小微企业。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CCNE vs PBYI — 直观对比
营收规模更大
CCNE
是对方的1.1倍
$75.5M
营收增速更快
CCNE
高出17.8%
27.7%
自由现金流更多
CCNE
多$44.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
26.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.4M | $75.5M |
| 净利润 | $20.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 48.4% | 22.7% |
| 净利率 | 24.0% | — |
| 营收同比 | 45.5% | 27.7% |
| 净利润同比 | 37.4% | — |
| 每股收益（稀释后） | $0.69 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCNEPBYI
| Q4 25 | $86.4M | $75.5M | ||
| Q3 25 | $77.7M | $54.5M | ||
| Q2 25 | $61.2M | $52.4M | ||
| Q1 25 | $56.9M | $46.0M | ||
| Q4 24 | $59.4M | $59.1M | ||
| Q3 24 | $58.5M | $80.5M | ||
| Q2 24 | $54.6M | $47.1M | ||
| Q1 24 | $54.2M | $43.8M |
净利润CCNEPBYI
| Q4 25 | $20.7M | — | ||
| Q3 25 | $20.0M | $8.8M | ||
| Q2 25 | $14.0M | $5.9M | ||
| Q1 25 | $11.5M | $3.0M | ||
| Q4 24 | $15.1M | — | ||
| Q3 24 | $14.0M | $20.3M | ||
| Q2 24 | $13.0M | $-4.5M | ||
| Q1 24 | $12.6M | $-4.8M |
毛利率CCNEPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CCNEPBYI
| Q4 25 | 48.4% | 22.7% | ||
| Q3 25 | 11.7% | 17.6% | ||
| Q2 25 | 28.2% | 12.7% | ||
| Q1 25 | 25.2% | 8.7% | ||
| Q4 24 | 31.4% | 22.6% | ||
| Q3 24 | 29.6% | 27.4% | ||
| Q2 24 | 29.3% | -4.6% | ||
| Q1 24 | 28.5% | -5.3% |
净利率CCNEPBYI
| Q4 25 | 24.0% | — | ||
| Q3 25 | 25.7% | 16.2% | ||
| Q2 25 | 22.8% | 11.2% | ||
| Q1 25 | 20.2% | 6.5% | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 23.9% | 25.2% | ||
| Q2 24 | 23.7% | -9.6% | ||
| Q1 24 | 23.3% | -11.0% |
每股收益（稀释后）CCNEPBYI
| Q4 25 | $0.69 | $0.26 | ||
| Q3 25 | $0.69 | $0.17 | ||
| Q2 25 | $0.61 | $0.12 | ||
| Q1 25 | $0.50 | $0.06 | ||
| Q4 24 | $0.67 | $0.40 | ||
| Q3 24 | $0.61 | $0.41 | ||
| Q2 24 | $0.56 | $-0.09 | ||
| Q1 24 | $0.55 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $527.9M | $97.5M |
| 总债务越低越好 | $84.9M | $22.7M |
| 股东权益账面价值 | $872.1M | $130.3M |
| 总资产 | $8.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.10× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CCNEPBYI
| Q4 25 | $527.9M | $97.5M | ||
| Q3 25 | $438.1M | $94.4M | ||
| Q2 25 | $425.4M | $96.0M | ||
| Q1 25 | $520.2M | $93.2M | ||
| Q4 24 | $443.0M | $101.0M | ||
| Q3 24 | $360.9M | $96.7M | ||
| Q2 24 | $331.1M | $96.8M | ||
| Q1 24 | $301.5M | $107.2M |
总债务CCNEPBYI
| Q4 25 | $84.9M | $22.7M | ||
| Q3 25 | $84.8M | $34.0M | ||
| Q2 25 | $84.7M | $45.3M | ||
| Q1 25 | $84.6M | $56.7M | ||
| Q4 24 | $84.6M | $68.0M | ||
| Q3 24 | $84.5M | $79.3M | ||
| Q2 24 | $84.4M | $90.7M | ||
| Q1 24 | $84.3M | $102.0M |
股东权益CCNEPBYI
| Q4 25 | $872.1M | $130.3M | ||
| Q3 25 | $844.2M | $115.3M | ||
| Q2 25 | $637.3M | $104.7M | ||
| Q1 25 | $624.5M | $97.1M | ||
| Q4 24 | $610.7M | $92.1M | ||
| Q3 24 | $606.4M | $71.1M | ||
| Q2 24 | $586.7M | $48.5M | ||
| Q1 24 | $578.6M | $51.0M |
总资产CCNEPBYI
| Q4 25 | $8.4B | $216.3M | ||
| Q3 25 | $8.3B | $202.9M | ||
| Q2 25 | $6.3B | $194.9M | ||
| Q1 25 | $6.3B | $196.2M | ||
| Q4 24 | $6.2B | $213.3M | ||
| Q3 24 | $6.0B | $220.7M | ||
| Q2 24 | $5.9B | $205.0M | ||
| Q1 24 | $5.8B | $214.1M |
负债/权益比CCNEPBYI
| Q4 25 | 0.10× | 0.17× | ||
| Q3 25 | 0.10× | 0.30× | ||
| Q2 25 | 0.13× | 0.43× | ||
| Q1 25 | 0.14× | 0.58× | ||
| Q4 24 | 0.14× | 0.74× | ||
| Q3 24 | 0.14× | 1.12× | ||
| Q2 24 | 0.14× | 1.87× | ||
| Q1 24 | 0.15× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $58.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 67.9% | 19.1% |
| 资本支出强度资本支出/营收 | 7.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.14× | — |
| 过去12个月自由现金流最近4个季度 | $91.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CCNEPBYI
| Q4 25 | $65.0M | $14.4M | ||
| Q3 25 | $7.0M | $9.7M | ||
| Q2 25 | $20.2M | $14.1M | ||
| Q1 25 | $11.6M | $3.6M | ||
| Q4 24 | $71.5M | $15.6M | ||
| Q3 24 | $26.4M | $11.0M | ||
| Q2 24 | $10.4M | $1.0M | ||
| Q1 24 | $12.5M | $11.2M |
自由现金流CCNEPBYI
| Q4 25 | $58.7M | $14.4M | ||
| Q3 25 | $4.9M | $9.7M | ||
| Q2 25 | $17.9M | $14.1M | ||
| Q1 25 | $9.9M | $3.6M | ||
| Q4 24 | $55.2M | $15.6M | ||
| Q3 24 | $22.2M | $11.0M | ||
| Q2 24 | $4.1M | $1.0M | ||
| Q1 24 | $10.0M | — |
自由现金流率CCNEPBYI
| Q4 25 | 67.9% | 19.1% | ||
| Q3 25 | 6.4% | 17.7% | ||
| Q2 25 | 29.2% | 26.8% | ||
| Q1 25 | 17.3% | 7.7% | ||
| Q4 24 | 93.0% | 26.4% | ||
| Q3 24 | 38.0% | 13.7% | ||
| Q2 24 | 7.6% | 2.1% | ||
| Q1 24 | 18.5% | — |
资本支出强度CCNEPBYI
| Q4 25 | 7.3% | 0.0% | ||
| Q3 25 | 2.7% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 27.4% | 0.0% | ||
| Q3 24 | 7.1% | 0.0% | ||
| Q2 24 | 11.6% | 0.0% | ||
| Q1 24 | 4.5% | 0.0% |
现金转化率CCNEPBYI
| Q4 25 | 3.14× | — | ||
| Q3 25 | 0.35× | 1.10× | ||
| Q2 25 | 1.45× | 2.41× | ||
| Q1 25 | 1.01× | 1.21× | ||
| Q4 24 | 4.75× | — | ||
| Q3 24 | 1.89× | 0.54× | ||
| Q2 24 | 0.81× | — | ||
| Q1 24 | 0.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
